ConductScience.org, home

Paper23738751

Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.

Pierce CG and 1 other. Expert Opin Drug Discov, 2013. Cited by 108 papers, by iCite.

Cite this record

ConductScience Library. Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Papers, record 23738751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23738751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.
PubMed
Journal
Expert Opin Drug Discov
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
PubMed
Citations, by iCite
108
iCite
Relative citation ratio, by iCite
4.4
iCite
Revised in PubMed
2022-03-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pierce CGChristopher G
2Lopez-Ribot JLJose L

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
Candida albicansMajor topic
Drug DiscoveryMajor topic
Animals
Biofilms
Candidiasis
Drug Resistance, Fungal
Humans
Virulence

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 DE023510NIDCR NIH HHSUnited StatesR01DE023510PubMed and NIH
1R01DE023510NIDCR NIH HHSUnited StatesR01DE023510PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115842329Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.Mycoses2005https://conductscience.org/library/papers/15842329PubMed
29204892Control of filament formation in Candida albicans by the transcriptional repressor TUP1.Science1997https://conductscience.org/library/papers/9204892PubMed
322174935Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans.PLoS One2011https://conductscience.org/library/papers/22174935PubMed
423689719High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23689719PubMed
512819929Adaptation to environmental pH in Candida albicans and its relation to pathogenesis.Curr Genet2003https://conductscience.org/library/papers/12819929PubMed
610706172Intravascular catheter-associated infections.Eur J Clin Microbiol Infect Dis2000https://conductscience.org/library/papers/10706172PubMed
722052380Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis.J Basic Microbiol2012https://conductscience.org/library/papers/22052380PubMed
818794385Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18794385PubMed
916815078Candida albicans biofilm development, modeling a host-pathogen interaction.Curr Opin Microbiol2006https://conductscience.org/library/papers/16815078PubMed
1012204378The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans.FEMS Microbiol Lett2002https://conductscience.org/library/papers/12204378PubMed
1121633704Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease.PLoS One2011https://conductscience.org/library/papers/21633704PubMed
1215554963A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology.Mol Microbiol2004https://conductscience.org/library/papers/15554963PubMed
1323180477Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.J Med Microbiol2013https://conductscience.org/library/papers/23180477PubMed
1415964263Candida albicans biofilms: more than filamentation.Curr Biol2005https://conductscience.org/library/papers/15964263PubMed
1517283095Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.Infect Immun2007https://conductscience.org/library/papers/17283095PubMed
1615043393Candida biofilms: antifungal resistance and emerging therapeutic options.Curr Opin Investig Drugs2004https://conductscience.org/library/papers/15043393PubMed
1716499417Use of genome information for the study of the pathogenesis of fungal infections and the development of diagnostic tools.Rev Iberoam Micol2005https://conductscience.org/library/papers/16499417PubMed
1819191635Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.Clin Infect Dis2009https://conductscience.org/library/papers/19191635PubMed
1911276429Fungal virulence studies come of age.Genome Biol2001https://conductscience.org/library/papers/11276429PubMed
2019863383Our current understanding of fungal biofilms.Crit Rev Microbiol2009https://conductscience.org/library/papers/19863383PubMed

See all 101 referencesDownload CSV of references

Cited by71

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.

PMIDTitleJournalYearIn PapersSource
42789947Emerging antifungal strategies against Candida albicans using metal-organic frameworks and novel therapeutics: Opportunities and challenges.J Food Drug Anal2026https://conductscience.org/library/papers/42789947PubMed
42743133Inhibitory effect and safety of Angelica dahurica-Ligusticum sinense extracts against Malassezia furfur and its biofilms.PLoS One2026https://conductscience.org/library/papers/42743133PubMed
42052383α-Glucosidase-driven metabolism as a potential therapeutic vulnerability in Candida albicans.Front Microbiol2026https://conductscience.org/library/papers/42052383PubMed
41968200High throughput screen reveals four compounds with novel antifungal activity, including a metal-responsive candidate with in vivo efficacy against Candida albicans.Sci Rep2026https://conductscience.org/library/papers/41968200PubMed
41963613Inhibition of Candida albicans yeast-to-hypha transition and virulence by cyclic dipeptides derived from probiotic Aeromonas veronii V03.Sci Rep2026https://conductscience.org/library/papers/41963613PubMed
41768734Impact of Metal-Functionalized Fullerenes on the Proliferation of Pathogenic Fungi.ACS Omega2026https://conductscience.org/library/papers/41768734PubMed
41731937How nettle (Urtica dioica) 'stings' Candida albicans by affecting its virulence factors.J Biosci2026https://conductscience.org/library/papers/41731937PubMed
41306651The adaptability of the fungal tRNA ligase's ATP-binding pocket: a potential target for new antifungal drugs.NAR Mol Med2025https://conductscience.org/library/papers/41306651PubMed
40792184Impact of Clove Oil on Biofilm Formation in Candida albicans and Its Effects on Mice with Candida Vaginitis.Mycobiology2025https://conductscience.org/library/papers/40792184PubMed
40666459Structural Optimization of Antifungal Peptoids targeting Candida albicans.ACS Med Chem Lett2025https://conductscience.org/library/papers/40666459PubMed
40100410A Novel Benzopyrone Derivative from Streptomyces chrestomyceticus ADP4 Inhibits Growth and Virulence Factors of Candida albicans.Curr Microbiol2025https://conductscience.org/library/papers/40100410PubMed
39404356The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species.mBio2024https://conductscience.org/library/papers/39404356PubMed
38789465Mitigating candidiasis with acarbose by targeting Candida albicans α-glucosidase: in-silico, in-vitro and transcriptomic approaches.Sci Rep2024https://conductscience.org/library/papers/38789465PubMed
38774301The impacts of animal agriculture on One Health-Bacterial zoonosis, antimicrobial resistance, and beyond.One Health2024https://conductscience.org/library/papers/38774301PubMed
38449801Antibiofilm Activity of Curcumin and Piperine and Their Synergistic Effects with Antifungals against Candida albicans Clinical Isolates.Scientifica (Cairo)2024https://conductscience.org/library/papers/38449801PubMed
36982520Potential Anti-Candida albicans Mechanism of Trichoderma Acid from Trichoderma spirale.Int J Mol Sci2023https://conductscience.org/library/papers/36982520PubMed
36742131Phytochemical Analysis, Antifungal, and Antioxidant Properties of Two Herbs (Tristemma mauritianum and Crassocephalum bougheyanum) and One Tree (Lavigeria macrocarpa) Species.Adv Pharmacol Pharm Sci2023https://conductscience.org/library/papers/36742131PubMed
36675832Non-albicans Candida Species: Immune Response, Evasion Mechanisms, and New Plant-Derived Alternative Therapies.J Fungi (Basel)2022https://conductscience.org/library/papers/36675832PubMed
36671380Chemical Profile, Anti-Microbial and Anti-Inflammaging Activities of Santolina rosmarinifolia L. Essential Oil from Portugal.Antibiotics (Basel)2023https://conductscience.org/library/papers/36671380PubMed
36100802Curcumin nanoparticles: the topical antimycotic suspension treating oral candidiasis.Odontology2023https://conductscience.org/library/papers/36100802PubMed

See all 71 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23738751

GET https://conductscience.org/api/papers/v1/23738751/references?page=2